CN103169903A - 一种治疗小儿支气管炎的中药制剂及其制备方法 - Google Patents
一种治疗小儿支气管炎的中药制剂及其制备方法 Download PDFInfo
- Publication number
- CN103169903A CN103169903A CN2012105832791A CN201210583279A CN103169903A CN 103169903 A CN103169903 A CN 103169903A CN 2012105832791 A CN2012105832791 A CN 2012105832791A CN 201210583279 A CN201210583279 A CN 201210583279A CN 103169903 A CN103169903 A CN 103169903A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- preparation
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 129
- 238000002360 preparation method Methods 0.000 title claims abstract description 65
- 206010006451 bronchitis Diseases 0.000 title claims abstract description 28
- 229940079593 drug Drugs 0.000 claims abstract description 37
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims abstract description 22
- 239000010231 banlangen Substances 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 235000004347 Perilla Nutrition 0.000 claims abstract description 5
- 241000951473 Schizonepeta Species 0.000 claims abstract description 5
- 238000011282 treatment Methods 0.000 claims description 43
- 241000628997 Flos Species 0.000 claims description 37
- 238000010438 heat treatment Methods 0.000 claims description 35
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 32
- 239000000843 powder Substances 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 21
- 238000000605 extraction Methods 0.000 claims description 21
- 239000000243 solution Substances 0.000 claims description 20
- 238000010992 reflux Methods 0.000 claims description 14
- 238000000108 ultra-filtration Methods 0.000 claims description 14
- 230000002829 reductive effect Effects 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 9
- 241000545442 Radix Species 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 7
- 238000002481 ethanol extraction Methods 0.000 claims description 7
- 239000002552 dosage form Substances 0.000 claims description 6
- 238000007873 sieving Methods 0.000 claims description 6
- 239000007921 spray Substances 0.000 claims description 6
- 241000605447 Anemarrhena Species 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 235000012907 honey Nutrition 0.000 claims description 5
- 239000013618 particulate matter Substances 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 5
- 238000001694 spray drying Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 241000209128 Bambusa Species 0.000 claims description 4
- 241000555712 Forsythia Species 0.000 claims description 4
- 241000245240 Lonicera Species 0.000 claims description 4
- 241000219780 Pueraria Species 0.000 claims description 4
- 241000207929 Scutellaria Species 0.000 claims description 4
- 241000405217 Viola <butterfly> Species 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 238000002791 soaking Methods 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 238000010410 dusting Methods 0.000 claims description 3
- 239000000469 ethanolic extract Substances 0.000 claims description 3
- 238000007710 freezing Methods 0.000 claims description 3
- 230000008014 freezing Effects 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 235000011837 pasties Nutrition 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 2
- 239000008298 dragée Substances 0.000 claims description 2
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 239000011505 plaster Substances 0.000 claims description 2
- 238000004064 recycling Methods 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- -1 sublimed preparation Substances 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 230000008719 thickening Effects 0.000 claims description 2
- 241000229722 Perilla <angiosperm> Species 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 51
- 230000000694 effects Effects 0.000 abstract description 44
- 230000001717 pathogenic effect Effects 0.000 abstract description 29
- 230000006870 function Effects 0.000 abstract description 15
- 239000009636 Huang Qi Substances 0.000 abstract description 13
- 231100000331 toxic Toxicity 0.000 abstract description 12
- 230000002588 toxic effect Effects 0.000 abstract description 12
- 208000024891 symptom Diseases 0.000 abstract description 11
- 241000700605 Viruses Species 0.000 abstract description 7
- 244000052769 pathogen Species 0.000 abstract description 7
- 206010061218 Inflammation Diseases 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 6
- 208000015181 infectious disease Diseases 0.000 abstract description 6
- 230000004054 inflammatory process Effects 0.000 abstract description 6
- 235000011389 fruit/vegetable juice Nutrition 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 5
- 208000035475 disorder Diseases 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract description 4
- 230000001932 seasonal effect Effects 0.000 abstract description 4
- 244000124853 Perilla frutescens Species 0.000 abstract description 3
- 235000017166 Bambusa arundinacea Nutrition 0.000 abstract description 2
- 235000017491 Bambusa tulda Nutrition 0.000 abstract description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 abstract description 2
- 239000011425 bamboo Substances 0.000 abstract description 2
- 241001633574 Adenophora stricta Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000218671 Ephedra Species 0.000 abstract 1
- 241000234435 Lilium Species 0.000 abstract 1
- 244000082204 Phyllostachys viridis Species 0.000 abstract 1
- 241000756042 Polygonatum Species 0.000 abstract 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 230000005540 biological transmission Effects 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 206010011224 Cough Diseases 0.000 description 99
- 210000004072 lung Anatomy 0.000 description 78
- 201000010099 disease Diseases 0.000 description 46
- 206010062717 Increased upper airway secretion Diseases 0.000 description 37
- 208000026435 phlegm Diseases 0.000 description 37
- 210000004369 blood Anatomy 0.000 description 33
- 239000008280 blood Substances 0.000 description 33
- 210000000952 spleen Anatomy 0.000 description 30
- 231100000614 poison Toxicity 0.000 description 20
- 208000002193 Pain Diseases 0.000 description 18
- 206010037660 Pyrexia Diseases 0.000 description 18
- 230000036407 pain Effects 0.000 description 18
- 241001465754 Metazoa Species 0.000 description 17
- 206010036790 Productive cough Diseases 0.000 description 17
- 208000006673 asthma Diseases 0.000 description 17
- 206010007247 Carbuncle Diseases 0.000 description 15
- 230000007812 deficiency Effects 0.000 description 15
- 206010042674 Swelling Diseases 0.000 description 14
- 210000003734 kidney Anatomy 0.000 description 14
- 230000008961 swelling Effects 0.000 description 14
- 239000003172 expectorant agent Substances 0.000 description 13
- 230000003419 expectorant effect Effects 0.000 description 13
- 230000001737 promoting effect Effects 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 12
- 239000003440 toxic substance Substances 0.000 description 12
- 206010006448 Bronchiolitis Diseases 0.000 description 11
- 208000033809 Suppuration Diseases 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 11
- 210000000214 mouth Anatomy 0.000 description 11
- 230000001105 regulatory effect Effects 0.000 description 11
- 206010047700 Vomiting Diseases 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 208000037920 primary disease Diseases 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 230000008673 vomiting Effects 0.000 description 9
- 208000008454 Hyperhidrosis Diseases 0.000 description 8
- 206010030113 Oedema Diseases 0.000 description 8
- 210000001124 body fluid Anatomy 0.000 description 8
- 239000010839 body fluid Substances 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 210000000056 organ Anatomy 0.000 description 8
- 239000002574 poison Substances 0.000 description 8
- 230000001047 pyretic effect Effects 0.000 description 8
- 208000024794 sputum Diseases 0.000 description 8
- 210000003802 sputum Anatomy 0.000 description 8
- 230000035922 thirst Effects 0.000 description 8
- 210000002700 urine Anatomy 0.000 description 8
- 206010035664 Pneumonia Diseases 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 7
- 230000009471 action Effects 0.000 description 7
- 230000003110 anti-inflammatory effect Effects 0.000 description 7
- 230000001754 anti-pyretic effect Effects 0.000 description 7
- 230000003115 biocidal effect Effects 0.000 description 7
- 208000013116 chronic cough Diseases 0.000 description 7
- 230000035619 diuresis Effects 0.000 description 7
- 210000003026 hypopharynx Anatomy 0.000 description 7
- 201000007227 lymph node tuberculosis Diseases 0.000 description 7
- 238000005728 strengthening Methods 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- 210000001835 viscera Anatomy 0.000 description 7
- 239000003390 Chinese drug Substances 0.000 description 6
- 206010019233 Headaches Diseases 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- 229930182555 Penicillin Natural products 0.000 description 6
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 6
- 206010043458 Thirst Diseases 0.000 description 6
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 230000036760 body temperature Effects 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 206010022000 influenza Diseases 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 229940049954 penicillin Drugs 0.000 description 6
- 239000002510 pyrogen Substances 0.000 description 6
- 230000002269 spontaneous effect Effects 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 231100000419 toxicity Toxicity 0.000 description 6
- 230000001988 toxicity Effects 0.000 description 6
- 206010010904 Convulsion Diseases 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 201000000297 Erysipelas Diseases 0.000 description 5
- 208000015220 Febrile disease Diseases 0.000 description 5
- 206010023126 Jaundice Diseases 0.000 description 5
- 206010068319 Oropharyngeal pain Diseases 0.000 description 5
- 208000037656 Respiratory Sounds Diseases 0.000 description 5
- 206010057190 Respiratory tract infections Diseases 0.000 description 5
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 5
- 208000025865 Ulcer Diseases 0.000 description 5
- 230000000954 anitussive effect Effects 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 210000000621 bronchi Anatomy 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 230000036461 convulsion Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 210000000265 leukocyte Anatomy 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 230000035900 sweating Effects 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 4
- 201000007100 Pharyngitis Diseases 0.000 description 4
- 208000036142 Viral infection Diseases 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 230000000840 anti-viral effect Effects 0.000 description 4
- 239000002221 antipyretic Substances 0.000 description 4
- 229940124584 antitussives Drugs 0.000 description 4
- 210000000436 anus Anatomy 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 4
- 230000006735 deficit Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 208000017574 dry cough Diseases 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 208000001780 epistaxis Diseases 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 235000008216 herbs Nutrition 0.000 description 4
- 230000003211 malignant effect Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 230000003449 preventive effect Effects 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- 206010040872 skin infection Diseases 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 230000009385 viral infection Effects 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 201000005702 Pertussis Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 206010047924 Wheezing Diseases 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000001088 anti-asthma Effects 0.000 description 3
- 230000001166 anti-perspirative effect Effects 0.000 description 3
- 239000003213 antiperspirant Substances 0.000 description 3
- 238000002555 auscultation Methods 0.000 description 3
- 208000013219 diaphoresis Diseases 0.000 description 3
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 3
- 208000028659 discharge Diseases 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 201000003453 lung abscess Diseases 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 201000009240 nasopharyngitis Diseases 0.000 description 3
- 230000000242 pagocytic effect Effects 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 206010037833 rales Diseases 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241001662414 Aster tataricus Species 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 241000596154 Belamcanda Species 0.000 description 2
- 208000031648 Body Weight Changes Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 241000167880 Hirundinidae Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 208000035756 Infantile asthma Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 208000019693 Lung disease Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 206010039101 Rhinorrhoea Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 206010044302 Tracheitis Diseases 0.000 description 2
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- 238000012742 biochemical analysis Methods 0.000 description 2
- 230000004579 body weight change Effects 0.000 description 2
- 201000009267 bronchiectasis Diseases 0.000 description 2
- 229960003291 chlorphenamine Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 206010014599 encephalitis Diseases 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000002489 hematologic effect Effects 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 238000009169 immunotherapy Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000000867 larynx Anatomy 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 208000010753 nasal discharge Diseases 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000001995 reticulocyte Anatomy 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 201000002882 Agraphia Diseases 0.000 description 1
- 241001093951 Ailanthus altissima Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 244000218454 Bambusa tulda Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 201000004813 Bronchopneumonia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010011376 Crepitations Diseases 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000371997 Eriocheir sinensis Species 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 241000124079 Mylabris Species 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010058117 Ocular icterus Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 240000007711 Peperomia pellucida Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 206010059411 Prolonged expiration Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000007123 Pulmonary Atelectasis Diseases 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 208000018569 Respiratory Tract disease Diseases 0.000 description 1
- 241000725643 Respiratory syncytial virus Species 0.000 description 1
- 206010038733 Respiratory tract malformation Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 206010042220 Stress ulcer Diseases 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 102000007501 Thymosin Human genes 0.000 description 1
- 108010046075 Thymosin Proteins 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 108010074506 Transfer Factor Proteins 0.000 description 1
- HLXRWTJXGMHOFN-UHFFFAOYSA-N Verbenalin Natural products C12C(C)CC(=O)C2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O HLXRWTJXGMHOFN-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical class N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229930191283 anemarrhena Natural products 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000410 anti-febrile effect Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000003157 atrial septum Anatomy 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229940066493 expectorants Drugs 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 210000002816 gill Anatomy 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000003721 gunpowder Substances 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000020985 infant symptom Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000008929 jingui shenqi Substances 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000004493 neutrocyte Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 230000001846 repelling effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 201000004193 respiratory failure Diseases 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 208000023409 throat pain Diseases 0.000 description 1
- LCJVIYPJPCBWKS-NXPQJCNCSA-N thymosin Chemical compound SC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CO)C(=O)N[C@H](CO)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(O)=O)C(O)=O LCJVIYPJPCBWKS-NXPQJCNCSA-N 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000008945 zhigancao decoction Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
免疫指标 | 西药治疗组 | 中药治疗组 |
IgG(g/L) | 7.12±0.14 | 7.89±0.19 |
IgA(g/L) | 8.16±0.46 | 8.87±0.26 |
IgM(g/L) | 0.97±0.14 | 1.13±0.27 |
CD3+(%) | 47.1±1.7 | 56.9±1.6 |
CD4+(%) | 28.4±1.6 | 32.7±1.8 |
CD8+(%) | 23.4±1.9 | 24.6±1.2 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210583279.1A CN103169903B (zh) | 2012-12-28 | 2012-12-28 | 一种治疗小儿支气管炎的中药制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210583279.1A CN103169903B (zh) | 2012-12-28 | 2012-12-28 | 一种治疗小儿支气管炎的中药制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103169903A true CN103169903A (zh) | 2013-06-26 |
CN103169903B CN103169903B (zh) | 2014-12-03 |
Family
ID=48630390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210583279.1A Expired - Fee Related CN103169903B (zh) | 2012-12-28 | 2012-12-28 | 一种治疗小儿支气管炎的中药制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103169903B (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103656308A (zh) * | 2013-12-18 | 2014-03-26 | 张福娟 | 一种治疗支气管扩张的中药 |
CN103690757A (zh) * | 2014-01-03 | 2014-04-02 | 王红 | 一种治疗肺脾虚型小儿支气管炎的中药组合物 |
CN103920080A (zh) * | 2014-04-29 | 2014-07-16 | 周云飞 | 一种治疗急慢性支气管炎的中药 |
CN104623418A (zh) * | 2015-02-22 | 2015-05-20 | 李淑 | 一种治疗小儿急性支气管炎的药剂 |
CN104644926A (zh) * | 2014-06-10 | 2015-05-27 | 陈莉芬 | 治疗支气管哮喘的喷雾剂 |
CN104971192A (zh) * | 2015-07-09 | 2015-10-14 | 济南邦文医药科技有限公司 | 一种治疗婴幼儿喘息性支气管炎的中药 |
CN106421345A (zh) * | 2016-11-11 | 2017-02-22 | 东莞市百替生物科技有限公司 | 一种治疗支气管炎的中药制剂及制备方法 |
CN108498689A (zh) * | 2018-06-25 | 2018-09-07 | 利辛县运杰家庭农场 | 一种治疗小儿毛细支气管炎的中药组合物及其制备方法 |
WO2018210228A1 (zh) * | 2017-05-16 | 2018-11-22 | 贾洪章 | 抗病毒中药组合物及其制备方法和用途 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101147788A (zh) * | 2007-04-11 | 2008-03-26 | 秦庆吉 | 治疗感冒和上呼吸道感染及其肺部炎症的药物 |
CN101244161A (zh) * | 2008-03-03 | 2008-08-20 | 郭新美 | 一种治疗小儿支气管肺炎的中药制备方法 |
CN101829296A (zh) * | 2010-02-05 | 2010-09-15 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗肺不张的中药组合物及其制备方法 |
-
2012
- 2012-12-28 CN CN201210583279.1A patent/CN103169903B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101147788A (zh) * | 2007-04-11 | 2008-03-26 | 秦庆吉 | 治疗感冒和上呼吸道感染及其肺部炎症的药物 |
CN101244161A (zh) * | 2008-03-03 | 2008-08-20 | 郭新美 | 一种治疗小儿支气管肺炎的中药制备方法 |
CN101829296A (zh) * | 2010-02-05 | 2010-09-15 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗肺不张的中药组合物及其制备方法 |
Non-Patent Citations (3)
Title |
---|
南京中医药大学编著: "《中药大辞典》", 31 March 2006, 上海科学技术出版社 * |
郑缅华: "辨证治疗慢性支气管炎78例临床观察", 《新中医》 * |
黄小菊: "中医药治疗小儿支气管炎的概况", 《中医儿科杂志》 * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103656308A (zh) * | 2013-12-18 | 2014-03-26 | 张福娟 | 一种治疗支气管扩张的中药 |
CN103656308B (zh) * | 2013-12-18 | 2015-11-11 | 张福娟 | 一种治疗支气管扩张的中药 |
CN103690757A (zh) * | 2014-01-03 | 2014-04-02 | 王红 | 一种治疗肺脾虚型小儿支气管炎的中药组合物 |
CN103920080A (zh) * | 2014-04-29 | 2014-07-16 | 周云飞 | 一种治疗急慢性支气管炎的中药 |
CN104644926A (zh) * | 2014-06-10 | 2015-05-27 | 陈莉芬 | 治疗支气管哮喘的喷雾剂 |
CN104623418A (zh) * | 2015-02-22 | 2015-05-20 | 李淑 | 一种治疗小儿急性支气管炎的药剂 |
CN104971192A (zh) * | 2015-07-09 | 2015-10-14 | 济南邦文医药科技有限公司 | 一种治疗婴幼儿喘息性支气管炎的中药 |
CN106421345A (zh) * | 2016-11-11 | 2017-02-22 | 东莞市百替生物科技有限公司 | 一种治疗支气管炎的中药制剂及制备方法 |
WO2018210228A1 (zh) * | 2017-05-16 | 2018-11-22 | 贾洪章 | 抗病毒中药组合物及其制备方法和用途 |
US11235015B2 (en) | 2017-05-16 | 2022-02-01 | Hongzhang Jia | Antiviral Traditional Chinese Medicine composition and preparation method and use i'hereof |
JP7008368B2 (ja) | 2017-05-16 | 2022-02-10 | ホンチャン ジア | 抗ウィルス漢方薬組成物及びその調製方法並びに使用 |
CN108498689A (zh) * | 2018-06-25 | 2018-09-07 | 利辛县运杰家庭农场 | 一种治疗小儿毛细支气管炎的中药组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103169903B (zh) | 2014-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103169903B (zh) | 一种治疗小儿支气管炎的中药制剂及其制备方法 | |
CN101972338B (zh) | 一种治疗小儿上呼吸道感染的中药制剂及其制备方法 | |
CN102078473B (zh) | 一种治疗慢性乙型肝炎的中药制剂及其制备方法 | |
CN104435944A (zh) | 一种治疗小儿咳嗽的中药组合物及其制备方法 | |
CN104173980A (zh) | 流感清热解表的中药组合物及制备方法 | |
CN103041256B (zh) | 一种治疗小儿反复呼吸道感染的中药制剂 | |
CN105169212A (zh) | 一种用于治疗慢性胃炎的中药组合物 | |
CN103041257B (zh) | 治疗小儿发热高烧呼吸道感染的中药制剂 | |
CN104940485A (zh) | 一种治疗小儿哮喘的中药组合物及其制备方法 | |
CN104147574A (zh) | 治疗感冒发烧的清热解表中药组合物及制备方法 | |
CN103041255B (zh) | 治疗小儿咽喉肿痛呼吸道感染的中药制剂 | |
CN103007145B (zh) | 一种治疗小儿轮状病毒肠炎的中药组合物及其制备方法 | |
CN103495072B (zh) | 一种治疗支气管扩张病的中药组合物及其制备方法 | |
CN106267028A (zh) | 一种治疗肺炎的中药组合物及其制备方法 | |
CN103041258B (zh) | 治疗小儿呼吸道感染伴纳差不食的中药制剂 | |
CN104623615A (zh) | 一种治疗哮喘的药物 | |
CN104984237A (zh) | 一种中药组合物及其制备方法 | |
CN103041259B (zh) | 治疗小儿痰多咳嗽呼吸道感染的中药制剂 | |
CN106390081A (zh) | 一种用于治疗湿热病胃疼的中药组合物 | |
CN105963586A (zh) | 一种治疗肺脓肿的药物及其制备方法 | |
CN104147166B (zh) | 败血症初期清凉解毒饮及制法 | |
CN105267815A (zh) | 一种治疗小儿肺肾两虚型哮喘的喷雾剂及其制备方法 | |
CN105412643A (zh) | 一种治疗小儿水气凌心型哮喘的喷雾剂及其制备方法 | |
CN103656459A (zh) | 一种治疗肺脾两虚证型咳嗽的中药 | |
CN107812087A (zh) | 一种治疗带下增多的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 floor 801-A room 8 Applicant after: QINGDAO HUAREN TECHNOLOGY INCUBATOR Co.,Ltd. Address before: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 (Minmetals building) 11 1101-A Applicant before: Qingdao Huaren Information Technology Development Co.,Ltd. |
|
CB03 | Change of inventor or designer information |
Inventor after: Song Zhenyu Inventor after: Xiao Zhong Xu Inventor after: Xu Liming Inventor after: Zhang Xiuwei Inventor before: Sun Xia |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: SUN XIA TO: SONG ZHENYU SUI XIAOZHONG XU LIMING ZHANG XIUWEI Free format text: CORRECT: APPLICANT; FROM: QINGDAO HUAREN INFORMATION TECHNOLOGY DEVELOPMENT CO., LTD. TO: QINGDAO HUAREN TECHNOLOGY INCUBATOR CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Lin Shaobo Inventor before: Song Zhenyu Inventor before: Xiao Zhong Xu Inventor before: Xu Liming Inventor before: Zhang Xiuwei |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170628 Address after: 515000 Guangdong province Shantou Jinping District Chaoshan Road Lane 4 Patentee after: SHANTOU OLIVE BRANCH PHARMACEUTICAL Co.,Ltd. Address before: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 floor 801-A room 8 Patentee before: QINGDAO HUAREN TECHNOLOGY INCUBATOR Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141203 Termination date: 20211228 |
|
CF01 | Termination of patent right due to non-payment of annual fee |